Portable ultrasound in the emergency room can identify pulmonary embolism in patients having difficulty breathing, allowing for prompt treatment.
Portable ultrasound in the emergency room can identify pulmonary embolism in patients having difficulty breathing, allowing for prompt treatment.
Dr. Nicolas Mansencal from the cardiology department at the University Hospital Ambroise Paré in Paris and colleagues from hospitals around France studied 76 patients with suspected pulmonary embolism after D-dimer screening. Each patient in the study received helical chest CT, transthoracic echocardiography, and venous ultrasonography using simplified echo criteria. The researchers published their findings in the May issue of Echocardiography.
Of the initial 76 patients, 31 proved to have pulmonary embolism by the end of the research. The right ventricle was dilated in 17 of these 31, or 55%. Researchers directly visualized a clot in the lower limbs in 18 of the 31, or 58%. Only eight patients (26%) had both right ventricular dilation and deep vein thrombosis.
The combined strategy of echocardiography and venous ultrasound had a sensitivity of 87% and specificity of 69%. The sensitivity of the combined approach was significantly better than either method alone. In particular, in patients with difficulty breathing and other clinical signs pointing strongly toward pulmonary embolism, the combined ultrasound method had a sensitivity of 94% and a specificity of 100%.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Point-Of-Care Ultrasound Platform and AI Software for Neuraxial Procedures
July 17th 2025The dual FDA clearances for the Accuro 3S point-of-care ultrasound device and the SpineNav-AI machine learning-based software may enhance precision and safety with ultrasound-guided neuraxial procedures.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.